99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test

Completed

Conditions studied: Acute Coronary Syndrome

In brief

Prospective multicenter sample collection and testing study.

Key facts

Study ID

NCT02638311

Run by

Trinity Biotech

People needed

769

Starts

2015-05-01

Expected to finish

2015-07-01

Last updated by the study team

2015-12-23

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female at least 21 years of age at the time of enrollment in the study.
• Subjects with no medications or no changes in their medications in the last 3 months.
• Subjects with and without chronic stable morbidities (i.e., renal insufficiency, hypertension, diabetes, hypercholesterolemia, pulmonary disorders, coronary disease, musculoskeletal disorders, etc.).
• Subjects able to understand and sign the informed consent and the patient questionnaire.

You may not qualify if…

• Subjects with a history of heart failure and/or, having received treatment for heart failure.
• Subject with renal failure.
• Subjects with a history of unstable heart disease or angina complaints.
• Subjects with any change in their medication in the last 3 months (diabetics may have small variations in glucose medications but may not have unstable disease, or have suffered a diabetic crisis in the last 6 months).
• Any known acute infection in the last 30 days.
• Marathon runners or extreme athletes.
• Pregnant (self-reported).

Where it is running

• Thomas Jefferson University — Philadelphia, Pennsylvania, United States
• Medical Research South — Charleston, South Carolina, United States
• Tanner Clinic — Layton, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.